Level Four Advisory Services’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,428
Closed -$464K 809
2023
Q2
$464K Sell
1,428
-1,068
-43% -$305K 0.03% 494
2023
Q1
$584K Buy
2,496
+143
+6% +$36.1K 0.04% 382
2022
Q4
$593K Sell
2,353
-7
-0.3% -$1.49K 0.04% 358
2022
Q3
$419K Buy
2,360
+318
+16% +$63.9K 0.04% 347
2022
Q2
$373K Sell
2,042
-2,018
-50% -$402K 0.04% 398
2022
Q1
$1.04M Buy
4,060
+348
+9% +$79.5K 0.08% 233
2021
Q4
$854K Buy
+3,712
New +$906K 0.07% 284

Other funds holding INSP

Level Four Advisory Services's INSP Position: Q3 2023 in Review

Level Four Advisory Services sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 1,428 shares — an estimated $464K sold.

Level Four Advisory Services first reported a position in INSP in Q4 2021 and held it in 7 quarters. The position peaked at $1.04M in Q1 2022. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • Level Four Advisory Services reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Level Four Advisory Services sold 1,428 Inspire Medical Systems shares in Q3 2023, an estimated $464K.
  • Level Four Advisory Services first reported a position in Inspire Medical Systems in Q4 2021 and held it in 7 quarters.
  • Level Four Advisory Services's Inspire Medical Systems position peaked at $1.04M in Q1 2022.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Level Four Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.